Up a level |
Number of items: 1.
Kerr, Fiona, Sofola-Adesakin, Oyinkan, Ivanov, Dobril K, Gatliff, Jemma, Gomez Perez-Nievas, Beatriz, Bertrand, Hélène C, Martinez, Pedro, Callard, Rebecca, Snoeren, Inge, Cochemé, Helena M et al (show 7 more authors)
(2017)
Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer’s disease.
PLOS Genetics, 13 (3).
e1006593-e1006593.